NCT05992129 is a NA clinical trial of foot exercise in Healthy, sponsored by Universidad del Magdalena.

Who is sponsoring NCT05992129?

NCT05992129 is sponsored by Universidad del Magdalena.

What drugs are being tested in NCT05992129?

Interventions in NCT05992129: foot exercise.

Is NCT05992129 still recruiting?

NCT05992129 is currently completed. Last updated 15 August 2023.

Last reviewed 2023-08-15 · How we verify

NCT05992129

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Foot Types on Collegiate Athletes

Completed NA Last updated 15 August 2023

What this trial tests

NA trial testing foot exercise in Healthy in 97 participants. Completed in 19 May 2023.

Timeline

1 August 2022

Primary endpoint
21 December 2022

19 May 2023

Quick facts

Lead sponsor	Universidad del Magdalena
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	97
Start date	1 August 2022
Primary completion	21 December 2022
Estimated completion	19 May 2023
Sites	1 location across Colombia

Drugs / interventions tested

foot exercise

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Universidad del Magdalena

Who can join

Adults 18 to 26, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to assess whether high or low arch foot types influence the overall performance of the athlete.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of foot exercise

Trials testing the same drug.

NCT06743074 — Effectiveness of Different Exercise Programmes in Individuals With Dynamic Knee Valgus · NA · completed

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05992129 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad del Magdalena
Last refreshed: 15 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05992129.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing